SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-109371
Filing Date
2021-08-25
Accepted
2021-08-25 17:01:10
Documents
12
Period of Report
2021-08-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2125922d1_8k.htm   iXBRL 8-K 25057
  Complete submission text file 0001104659-21-109371.txt   199719

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcli-20210820.xsd EX-101.SCH 3209
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20210820_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20210820_pre.xml EX-101.PRE 22726
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2125922d1_8k_htm.xml XML 3617
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 211207620
SIC: 2836 Biological Products, (No Diagnostic Substances)